Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides.

Pedersen SR, Christensen JP, Buus S, Rasmussen M, Korsholm KS, Nielsen M, Claesson MH.

PLoS One. 2016 Jan 5;11(1):e0145629. doi: 10.1371/journal.pone.0145629. eCollection 2016.

2.

Depletion of enteroantigen-activated CD4⁺ T cells: effects on proliferation and pathogenicity.

Belmaáti MS, Claesson MH.

Int Immunol. 2015 Sep;27(9):419-24. doi: 10.1093/intimm/dxv039. Epub 2015 Jun 30.

PMID:
26133188
3.

[The influence of melatonin on the immune system and cancer].

Vinther AG, Claësson MH.

Ugeskr Laeger. 2015 May 18;177(21):V10140568. Review. Danish.

PMID:
26027592
4.

Classification of human leukocyte antigen (HLA) supertypes.

Wang M, Claesson MH.

Methods Mol Biol. 2014;1184:309-17. doi: 10.1007/978-1-4939-1115-8_17.

PMID:
25048132
5.

Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival.

Aaby P, Martins CL, Garly ML, Andersen A, Fisker AB, Claesson MH, Ravn H, Rodrigues A, Whittle HC, Benn CS.

Clin Infect Dis. 2014 Aug 15;59(4):484-92. doi: 10.1093/cid/ciu354. Epub 2014 May 14.

6.

Antiproliferative effects of TRPV1 ligands on nonspecific and enteroantigen-specific T cells from wild-type and Trpv1 KO mice.

Belmaáti MS, Diemer S, Hvarness T, Baumann K, Pedersen AE, Christensen RE, Claesson MH.

Inflamm Bowel Dis. 2014 Jun;20(6):1004-14. doi: 10.1097/MIB.0000000000000039.

PMID:
24788222
7.

Enteroantigen (eAg)-binding B lymphocytes in the mouse - phenotype, distribution, function and eAg-specific antibody secretion.

Venning FA, Trempenau ML, Schmidt E, Claesson MH.

APMIS. 2014 Jul;122(7):616-27. doi: 10.1111/apm.12200. Epub 2013 Dec 5.

PMID:
24303790
8.

Phenotypic characterisation of immune cell infiltrates in testicular germ cell neoplasia.

Hvarness T, Nielsen JE, Almstrup K, Skakkebaek NE, Rajpert-De Meyts E, Claesson MH.

J Reprod Immunol. 2013 Dec;100(2):135-45. doi: 10.1016/j.jri.2013.10.005. Epub 2013 Nov 14.

PMID:
24290033
9.

B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells.

Kristensen NN, Schmidt EG, Rasmussen S, Balk-Møller E, Claesson MH.

Immunopharmacol Immunotoxicol. 2013 Aug;35(4):505-13. doi: 10.3109/08923973.2013.810642. Epub 2013 Jul 10.

PMID:
23841452
10.

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy.

Rasmussen S, Donskov F, Pedersen JW, Wandall HH, Buus S, Harndahl M, Braendstrup P, Claesson MH, Pedersen AE.

Immunopharmacol Immunotoxicol. 2013 Aug;35(4):487-96. doi: 10.3109/08923973.2013.802802. Epub 2013 Jun 27.

PMID:
23802595
11.

TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.

Wedebye Schmidt EG, Larsen HL, Kristensen NN, Poulsen SS, Lynge Pedersen AM, Claesson MH, Pedersen AE.

Inflamm Bowel Dis. 2013 Jul;19(8):1567-76. doi: 10.1097/MIB.0b013e318286fa1c.

PMID:
23689808
12.

Peptide pool immunization and CD8+ T cell reactivity.

Rasmussen SB, Harndahl MN, Stryhn A, Buus S, Claesson MH.

Immunol Lett. 2013 Mar;151(1-2):48-53. doi: 10.1016/j.imlet.2013.02.006. Epub 2013 Mar 13.

PMID:
23499579
13.

Wildtype p53-specific antibody and T-cell responses in cancer patients.

Pedersen AE, Stryhn A, Justesen S, Harndahl M, Rasmussen S, Donskov F, Claesson MH, Pedersen JW, Wandall HH, Svane IM, Buus S.

J Immunother. 2011 Nov-Dec;34(9):629-40. doi: 10.1097/CJI.0b013e3182281381.

PMID:
21989411
14.

SNP may modify the effect of vitamin A supplementation at birth on cytokine production in a whole blood culture assay.

Jørgensen MJ, Fisker AB, Erikstrup C, Claesson MH, Benn CS.

Br J Nutr. 2012 Mar;107(5):615-20. doi: 10.1017/S0007114511003515. Epub 2011 Jul 26.

PMID:
21791141
15.

Immunological Links to Nonspecific Effects of DTwP and BCG Vaccines on Infant Mortality.

Claesson MH.

J Trop Med. 2011;2011:706304. doi: 10.1155/2011/706304. Epub 2011 May 5.

16.

Limited effect of capsaicin in T-cell transfer colitis.

Claesson MH.

Inflamm Bowel Dis. 2011 Sep;17(9):E121. doi: 10.1002/ibd.21789. Epub 2011 Jun 14. No abstract available.

PMID:
21674729
17.

B cells exposed to enterobacterial components suppress development of experimental colitis.

Schmidt EG, Larsen HL, Kristensen NN, Poulsen SS, Claesson MH, Pedersen AE.

Inflamm Bowel Dis. 2012 Feb;18(2):284-93. doi: 10.1002/ibd.21769. Epub 2011 May 25.

PMID:
21618359
18.

Consumption of probiotics increases the effect of regulatory T cells in transfer colitis.

Petersen ER, Claesson MH, Schmidt EG, Jensen SS, Ravn P, Olsen J, Ouwehand AC, Kristensen NN.

Inflamm Bowel Dis. 2012 Jan;18(1):131-42. doi: 10.1002/ibd.21709. Epub 2011 Apr 14.

PMID:
21495121
19.

Dendritic cells modified by vitamin D: future immunotherapy for autoimmune diseases.

Pedersen AW, Claesson MH, Zocca MB.

Vitam Horm. 2011;86:63-82. doi: 10.1016/B978-0-12-386960-9.00003-4. Review.

PMID:
21419267
20.

Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Wang M, Tang ST, Stryhn A, Justesen S, Larsen MV, Dziegiel MH, Lewinsohn DM, Buus S, Lund O, Claesson MH.

Immunology. 2011 Apr;132(4):482-91. doi: 10.1111/j.1365-2567.2010.03383.x. Epub 2011 Feb 7.

21.

Enteroantigen-presenting B cells efficiently stimulate CD4(+) T cells in vitro.

Schmidt EG, Kristensen NN, Claesson MH, Pedersen AE.

Inflamm Bowel Dis. 2011 Jan;17(1):308-18. doi: 10.1002/ibd.21429. Epub 2010 Aug 18.

PMID:
20722062
22.

Why current peptide-based cancer vaccines fail: lessons from the three Es.

Claesson MH.

Immunotherapy. 2009 Jul;1(4):513-6. doi: 10.2217/imt.09.35. No abstract available.

23.

HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.

Wang M, Larsen MV, Nielsen M, Harndahl M, Justesen S, Dziegiel MH, Buus S, Tang ST, Lund O, Claesson MH.

PLoS One. 2010 May 7;5(5):e10533. doi: 10.1371/journal.pone.0010533.

24.

Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients.

Toh HC, Wang WW, Chia WK, Kvistborg P, Sun L, Teo K, Phoon YP, Soe Y, Tan SH, Hee SW, Foo KF, Ong S, Koo WH, Zocca MB, Claesson MH.

Clin Cancer Res. 2009 Dec 15;15(24):7726-7736.

25.

Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination.

Burgdorf SK, Claesson MH, Nielsen HJ, Rosenberg J.

Acta Oncol. 2009;48(8):1157-64. doi: 10.3109/02841860903099964.

PMID:
19863224
26.

Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors.

Kvistborg P, Bechmann CM, Pedersen AW, Toh HC, Claesson MH, Zocca MB.

Vaccine. 2009 Dec 11;28(2):542-7. doi: 10.1016/j.vaccine.2009.09.129. Epub 2009 Nov 4.

PMID:
19837091
27.

Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy.

Holmstrøm K, Pedersen AW, Claesson MH, Zocca MB, Jensen SS.

Hum Immunol. 2010 Jan;71(1):67-73. doi: 10.1016/j.humimm.2009.10.001.

PMID:
19819280
28.

Fast generation of dendritic cells.

Kvistborg P, Boegh M, Pedersen AW, Claesson MH, Zocca MB.

Cell Immunol. 2009;260(1):56-62. doi: 10.1016/j.cellimm.2009.09.003. Epub 2009 Sep 11.

PMID:
19818956
29.

Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.

Weinert BT, Krishnadath KK, Milano F, Pedersen AW, Claesson MH, Zocca MB.

Cancer Immun. 2009 Oct 9;9:9.

30.

Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.

Schmidt EG, Claesson MH, Jensen SS, Ravn P, Kristensen NN.

Inflamm Bowel Dis. 2010 Mar;16(3):390-400. doi: 10.1002/ibd.21068.

PMID:
19714743
31.

Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells.

Pedersen AW, Holmstrøm K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, Claesson MH, Zocca MB.

Clin Exp Immunol. 2009 Jul;157(1):48-59. doi: 10.1111/j.1365-2249.2009.03961.x.

32.

Genome-wide gene expression profiling of SCID mice with T-cell-mediated Colitis.

Brudzewsky D, Pedersen AE, Claesson MH, Gad M, Kristensen NN, Lage K, Jensen T, Tommerup N, Larsen LA, Knudsen S, Tümer Z.

Scand J Immunol. 2009 May;69(5):437-46. doi: 10.1111/j.1365-3083.2009.02243.x. Epub 2009 Feb 26.

33.

Blockage of the neurokinin 1 receptor and capsaicin-induced ablation of the enteric afferent nerves protect SCID mice against T-cell-induced chronic colitis.

Gad M, Pedersen AE, Kristensen NN, Fernandez Cde F, Claesson MH.

Inflamm Bowel Dis. 2009 Aug;15(8):1174-82. doi: 10.1002/ibd.20902.

PMID:
19326358
34.

Modified human beta 2-microglobulin (desLys(58)) displays decreased affinity for the heavy chain of MHC class I and induces nitric oxide production and apoptosis.

Wang M, Harhaji L, Lamberth K, Harndahl M, Buus S, Heegaard NH, Claesson MH, Nissen MH.

Scand J Immunol. 2009 Mar;69(3):203-12. doi: 10.1111/j.1365-3083.2008.02213.x.

35.

High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.

Wang M, Tang ST, Lund O, Dziegiel MH, Buus S, Claesson MH.

Clin Exp Immunol. 2009 Mar;155(3):441-6. doi: 10.1111/j.1365-2249.2008.03856.x.

36.

No effect on survival of home psychosocial intervention in a randomized study of Danish colorectal cancer patients.

Ross L, Frederiksen K, Boesen SH, Karlsen RV, Rasmussen MS, Sørensen LT, Jørgensen T, Claesson MH, Johansen C.

Psychooncology. 2009 Aug;18(8):875-85. doi: 10.1002/pon.1524.

PMID:
19137506
37.

Future targets for immune therapy in colitis?

Kristensen NN, Claesson MH.

Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):295-300. Review.

PMID:
19075783
38.

Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine.

Burgdorf SK, Fischer A, Myschetzky PS, Munksgaard SB, Zocca MB, Claesson MH, Rosenberg J.

Oncol Rep. 2008 Dec;20(6):1305-11.

PMID:
19020707
39.

Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model.

Pedersen AE, Schmidt EG, Gad M, Poulsen SS, Claesson MH.

Immunology. 2009 Jul;127(3):354-64. doi: 10.1111/j.1365-2567.2008.02996.x. Epub 2008 Nov 19.

40.

Peptide specific expansion of CD8(+) T cells by recombinant plate bound MHC/peptide complexes.

Schmidt EG, Buus S, Thorn M, Stryhn A, Leisner C, Claesson MH.

J Immunol Methods. 2009 Jan 1;340(1):25-32. doi: 10.1016/j.jim.2008.09.020. Epub 2008 Oct 23.

PMID:
18950635
41.

MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.

Tang ST, Wang M, Lamberth K, Harndahl M, Dziegiel MH, Claesson MH, Buus S, Lund O.

Arch Virol. 2008;153(10):1833-44. doi: 10.1007/s00705-008-0194-7. Epub 2008 Sep 12.

42.

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.

Berntsen A, Trepiakas R, Wenandy L, Geertsen PF, thor Straten P, Andersen MH, Pedersen AE, Claesson MH, Lorentzen T, Johansen JS, Svane IM.

J Immunother. 2008 Oct;31(8):771-80. doi: 10.1097/CJI.0b013e3181833818.

PMID:
18779742
43.

Interactions between infections and immune-inflammatory cells in type 1 diabetes mellitus and inflammatory bowel diseases: evidences from animal models.

Claesson MH, Nicoletti F, Stosic-Grujicic S, Doria A, Zampieri S.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S8-11. Review.

PMID:
18570748
44.

Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53.

Honoré B, Buus S, Claësson MH.

Proteome Sci. 2008 Jun 10;6:18. doi: 10.1186/1477-5956-6-18.

45.

Cellular cross talk in the small intestinal mucosa: postnatal lymphocytic immigration elicits a specific epithelial transcriptional response.

Schjoldager KT, Maltesen HR, Balmer S, Lund LR, Claesson MH, Sjöström H, Troelsen JT, Olsen J.

Am J Physiol Gastrointest Liver Physiol. 2008 Jun;294(6):G1335-43. doi: 10.1152/ajpgi.00265.2007. Epub 2008 Apr 3.

46.

Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complex.

Wang M, Corlin DB, Heegaard NH, Claesson MH, Nissen MH.

Scand J Immunol. 2008 Feb;67(2):105-12. Epub 2007 Dec 7.

47.

Genome-wide expression profiling during protection from colitis by regulatory T cells.

Kristensen NN, Olsen J, Gad M, Claesson MH.

Inflamm Bowel Dis. 2008 Jan;14(1):75-87.

PMID:
17924563
49.

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope.

Thorn M, Wang M, Kløverpris H, Schmidt EG, Fomsgaard A, Wenandy L, Berntsen A, Brunak S, Buus S, Claesson MH.

Cancer Immunol Immunother. 2007 Nov;56(11):1755-63. Epub 2007 Apr 27.

PMID:
17464507
50.

Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model.

Pedersen AE, Gad M, Kristensen NN, Haase C, Nielsen CH, Claesson MH.

Immunology. 2007 Aug;121(4):526-32. Epub 2007 Apr 12.

Supplemental Content

Loading ...
Support Center